Neurotek

Neurotek was founded with the vision of providing new, modern solutions for attentional profiling aimed at unlocking the potential of every individual. Our flagship product MOXO is the industry’s leading fully online and cloud-based, validated Continuous Performance Test (CPT). Our MOXO cloud-based digital assessment provides both accurate diagnostic support and a scientific assessment of human attention. Used by numerous institutes and clinics worldwide, MOXO Diagnosis provides an objective and detailed assessment for the screening and diagnostic support of attention difficulties and deficits. With the experience and knowledge resulting from running close to a million MOXO assessments worldwide and over a hundred of peer-reviewed research publications and academic studies, Neurotek is expanding attentional profiling beyond the clinical realm, with MOXO Profiler – the industry’s first general population attention profiler, designed to encompass the entire attention spectrum. Learn more - www.moxo.ai